v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Common Stock
ATLASCLEAR, INC
Common Stock
Pacsquare
Common Stock
Additional Paid-in Capital
ATLASCLEAR, INC
Additional Paid-in Capital
Pacsquare
Additional Paid-in Capital
Accumulated Deficit
ATLASCLEAR, INC
Pacsquare
Total
Balance at Dec. 31, 2021     $ 503       $ (13,885,707)     $ (13,885,204)
Accretion of Common Stock subject to Possible Redemption             (2,170,202)     (2,170,202)
Net income (loss)             11,045,567     11,045,567
Balance at Dec. 31, 2022     $ 503       (5,010,342)     $ (5,009,839)
Ending balance (in shares) at Dec. 31, 2022     5,031,250             5,031,250
Balance at Dec. 31, 2022     $ 503       (5,010,342)     $ (5,009,839)
Ending balance (in shares) at Dec. 31, 2022     5,031,250             5,031,250
Balance at Dec. 31, 2022     $ 503       (5,010,342)     $ (5,009,839)
Ending balance (in shares) at Dec. 31, 2022     5,031,250             5,031,250
Accretion of Common Stock subject to Possible Redemption             (1,260,719)     $ (1,260,719)
Excise taxes related to redemptions             (1,485,236)     (1,485,236)
Net income (loss)             192,371     192,371
Balance at Mar. 31, 2023     $ 503       (7,563,926)     (7,563,423)
Ending balance (in shares) at Mar. 31, 2023     5,031,250              
Balance at Dec. 31, 2022     $ 503       (5,010,342)     $ (5,009,839)
Beginning balance (in shares) at Dec. 31, 2022     5,031,250             5,031,250
Accretion of Common Stock subject to Possible Redemption           $ (120,000) (3,888,446)     $ (4,008,446)
Net income (loss)             794,950     794,950
Balance at Dec. 31, 2023     $ 503       (11,513,379)     $ (11,512,876)
Ending balance (in shares) at Dec. 31, 2023     5,031,250             5,031,250
Balance at Dec. 31, 2023     $ 503       (11,513,379)     $ (11,512,876)
Ending balance (in shares) at Dec. 31, 2023     5,031,250             5,031,250
Balance at Dec. 31, 2023     $ 503       (11,513,379)     $ (11,512,876)
Ending balance (in shares) at Dec. 31, 2023     5,031,250             5,031,250
Common stock no longer subject to redemption     $ 11     1,195,555       $ 1,195,566
Common stock no longer subject to redemption (in shares)     109,499              
Common stock issued to settled vendor obligations     $ 32     1,513,068       1,513,100
Common stock issued to settled vendor obligations (in shares)     321,010              
Stock Compensation Expense - Founder Shares transferred at closing           1,462,650       1,462,650
Founder Shares transferred at closing to non-redemption agreement holders           1,606,279       1,606,279
Founder Shares transferred at closing as consideration for Wilson Davis Acquisition           8,850,100       8,850,100
Founder Shares and warrants transferred to Secured convertible note holders           1,003,632       1,003,632
Shares issued to settle related party advances and promissory notes     $ 200     4,577,369       $ 4,577,569
Shares issued to settle related party advances and promissory notes (in shares)     2,000,000              
Shares issued as purchase consideration for the assets $ 445 $ 34   $ 44,399,555 $ 1,115,966     $ 44,400,000 $ 1,116,000  
Shares issued as purchase consideration for the assets (in shares) 4,440,000 336,000           4,440,000   4,400,000
Earnout shares granted as purchase consideration for the assets of AtlasClear, Inc.       $ 31,347,000       $ 31,347,000    
Shares issued as deposit for the Commercial Bank acquisition     $ 4     91,196       $ 91,200
Shares issued as deposit for the Commercial Bank acquisition (in shares)     40,000              
Accretion of Common Stock subject to Possible Redemption             (592,577)     (592,577)
Excise taxes related to redemptions             (539,471)     (539,471)
Net income (loss)             (88,577,417)     (88,577,417)
Balance at Mar. 31, 2024     $ 1,229     $ 97,162,370 $ (101,222,844)     $ (4,059,245)
Ending balance (in shares) at Mar. 31, 2024     12,277,759             12,277,759